Skip to content

BMS data confirm potential for dosing ddI and tenofovir with food

HIV-positive HAART patients with PML and CD4 count below 100 at greatest risk of death

Doctors failing to warn HIV-HCV patients about alcohol risk, Veterans study reports

Gilead announces pricing, procedures for low-cost access to tenofovir

First European HIV Resistance Workshop highlights non-B subtypes, replicative capacity

HIV-positive asylum seeker loses appeal against dispersal from London

New British test may improve TB diagnosis rate

Confusion over use of nonoxynol-9 among gay men in San Francisco despite public warnings

Case report of kidney lesions in HIV-positive man treated with tenofovir